Clinical Trials Directory

Trials / Completed

CompletedNCT04081961

Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD

A Proof-of-concept, Open-label, Feasibility Study to Evaluate Mobile Applications and Biosensing (mHealth) Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms/COPD

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Kazakhstan Academy of Preventive Medicine · Academic / Other
Sex
All
Age
40 Years – 59 Years
Healthy volunteers
Accepted

Summary

This study examines the feasibility and acceptability of using mobile applications and biosensing (mHealth) devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate, blood oxygenation, steps/motion) for a future big-scale study.

Detailed description

The study is designed to investigate feasibility of using mHealth devices to improve the treatment, assessment, compliance, and outcomes in smokers with and without respiratory symptoms/COPD. The study aims to reveal and address the anticipated barriers to the acceptance and implementation of mHealth devices in this patient population and clinical setting. As is well documented, the more attention patients receive from medical personnel, the better their clinical outcomes. Here we are attempting to use device-driven monitoring applications, interactive reminders, and teaching modules to deliver a constant positive feedback loop to patients to improve their health decisions. Objectives of the study: To assess the feasibility of using mHealth devices in current smokers with and without respiratory symptoms/COPD. To assess the utility (i.e., validity and reproducibility) of mHealth devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate; blood oxygenation; steps/motion; FEV1, FVC, and their ratio; peak expiratory flow \[PEF\]).

Conditions

Interventions

TypeNameDescription
DEVICEAnamed OEM device; Air Next mobile spirometry deviceAnamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

Timeline

Start date
2019-06-07
Primary completion
2019-10-10
Completion
2019-10-31
First posted
2019-09-09
Last updated
2020-03-03
Results posted
2020-01-09

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT04081961. Inclusion in this directory is not an endorsement.